The Saccadic and Neurological Deficits in Type 3 Gaucher Disease

• William Benko ,

  Contributed equally to this work with: William Benko, Markus Ries

  Affiliation Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Markus Ries ,

  Contributed equally to this work with: William Benko, Markus Ries

  Affiliation University Children's Hospital, Pediatric Neurology, Heidelberg, Germany

  ⨯
• Edythe A. Wiggs,

  Affiliation Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Roscoe O. Brady,

  Affiliation Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Raphael Schiffmann ,

  * E-mail: Raphael.Schiffmann@Baylorhealth.edu

  Affiliations Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America, Institute of Metabolic Disease, Baylor Research Institute, Dallas, Texas, United States of America

  ⨯
• Edmond J. FitzGibbon

  Affiliation National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯